Over 40% of EFX 50mg participants experienced liver fibrosis regression after 96 weeks, demonstrating significant clinical efficacy.Quiver AI SummaryAkero Therapeutics announced promising results from...
Sagimet Biosciences’ SGMT stock rose 12.6% on Tuesday after it announced that the FDA has granted breakthrough therapy designation (“BTD”) to its lead pipeline candidate, denifanstat, for treating...
Stocks that traded heavily or had substantial price changes on Monday: Macy’s, United Rentals rise; Apple, Spirit Airlines fall
Akero's lead therapy fell short of its goals in a phase 2b trial to treat NASH.
What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...
Stocks that traded heavily or had substantial price changes on Tuesday: PepsiCo, Palantir rise; Neogen, Akero Therapeutics fall